Passa al contenuto
Merck

Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report.

Annals of hepatology (2013-01-08)
Ludovico Abenavoli, Natasa Milic, Michel Beaugrand
ABSTRACT

Cyproterone acetate (CPA) is an oral anti-androgen commonly used to treat advanced prostate cancer. A variety of hepatotoxic reactions has been reported with CPA. Here we describe a case of a male patient who developed severe drug-induced hepatotoxicity during the treatment with CPA. The case, presenting sub-acute hepatitis, was characterized by a rapid evolution of cirrhosis and a protracted activity during the period of a few months despite the treatment withdrawal and an apparent benefits of corticosteroids, suggesting their indication in life threatening cases.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Ursodeoxycholic acid, ≥99%
Sigma-Aldrich
Budesonide, ≥99%
Supelco
Budesonide, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Cyproterone acetate, ≥98%
Ursodeoxycholic acid, European Pharmacopoeia (EP) Reference Standard
Budesonide, European Pharmacopoeia (EP) Reference Standard
Ursodeoxycholic acid for system suitability, European Pharmacopoeia (EP) Reference Standard
Cyproterone acetate, European Pharmacopoeia (EP) Reference Standard